SCND SCIENTIFIC INDUSTRIES INC
Laboratory Analytical Instruments · OTC · SEC CIK 87802 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY20.6%
TTM net income YoY-244.6%
TTM EPS YoY-208.3%
Revenue 3-yr CAGR-19.6%
Net income 3-yr CAGR—
Margins
Gross margin31.3%
Operating margin-116.3%
Net margin-75.1%
FCF margin-110.6%
EBITDA margin-110.8%
Returns
ROE-40.4%
ROA-33.5%
ROIC (approx.)-56.1%
Asset turnover0.45x
Leverage & solvency
Liabilities / assets20.7%
Debt / equity0.00x
Current ratio6.43x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.46x
Accruals ratio15.4%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.35M | $1.47M | $1.23M | $1.63M | $1.40M | $1.08M | $942,300 | $1.28M |
| Cost of revenue | $611,900 | $847,700 | $757,200 | $1.69M | $765,400 | $704,300 | $598,000 | $827,400 |
| Gross profit | $742,900 | $622,700 | $469,900 | -$59,900 | $638,600 | $376,700 | $344,300 | $455,100 |
| R&D expense | $662,200 | $694,500 | $703,700 | $616,800 | $621,400 | $677,100 | $652,000 | $951,900 |
| SG&A expense | $677,200 | $553,900 | $746,900 | $697,400 | $803,600 | $744,800 | $1.03M | $1.24M |
| Operating income | -$1.21M | -$1.27M | -$1.67M | -$2.46M | -$1.52M | -$1.82M | -$2.09M | -$2.53M |
| Pretax income | $509,800 | -$1.23M | -$1.59M | -$1.92M | $4.00M | -$1.80M | -$2.06M | -$2.51M |
| Income tax | $39,800 | $0 | $0 | -$10,700 | $15,300 | $0 | $0 | $0 |
| Net income | $470,000 | -$1.23M | -$1.59M | -$1.91M | $3.99M | -$1.52M | -$1.78M | -$1.93M |
| EBITDA | -$1.16M | -$1.22M | -$1.61M | -$2.30M | -$1.39M | -$1.67M | -$1.92M | -$2.35M |
| EPS (diluted) | 0.04 | -0.10 | -0.13 | — | 0.34 | -0.13 | -0.16 | — |
| Weighted avg. shares (diluted) | 11.93M | 11.93M | 11.93M | — | 11.71M | 11.35M | 10.50M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.35M | $616,500 | $797,800 | $955,000 | $1.16M | $891,400 | $470,100 | $587,900 |
| Short-term investments | $4.62M | $3.93M | — | $5.71M | — | — | — | — |
| Receivables | $395,400 | $517,100 | $535,300 | $865,800 | $677,600 | $966,000 | $1.21M | $581,900 |
| Inventory | $2.17M | $1.94M | $1.57M | $1.75M | $2.04M | $4.39M | $4.35M | $2.06M |
| Current assets | $8.50M | $8.13M | $8.99M | $10.39M | $11.89M | $7.21M | $7.39M | $8.29M |
| PP&E, net | $570,600 | $604,400 | $637,600 | $690,900 | $765,600 | $906,600 | $899,400 | $796,300 |
| Goodwill | $115,300 | $115,300 | $115,300 | $115,300 | $115,300 | $115,300 | $115,300 | $115,300 |
| Intangibles | $79,100 | $81,000 | $92,000 | $103,500 | $449,300 | $530,800 | $626,300 | $752,300 |
| Total assets | $10.93M | $10.11M | $11.10M | $12.61M | $14.56M | $10.23M | $10.57M | $11.56M |
| Current liabilities | $1.32M | $1.60M | $1.45M | $1.35M | $1.55M | $1.70M | $2.13M | $1.75M |
| Total liabilities | $2.26M | $2.03M | $1.99M | $1.94M | $2.10M | $2.23M | $2.80M | $2.44M |
| Shareholders' equity | $8.67M | $8.07M | $9.12M | $10.66M | $12.46M | $7.92M | $7.77M | $9.12M |
| Shares outstanding | 11.93M | 11.93M | 11.93M | 11.93M | 11.93M | 11.55M | 10.50M | 10.50M |
| Cash flow statement | ||||||||
| Operating cash flow | -$577,400 | -$904,100 | -$993,500 | -$3.76M | -$1.63M | -$1.68M | -$1.52M | $1.14M |
| Capital expenditure | $14,800 | $8,300 | $6,200 | $19,600 | $10,400 | $6,900 | $26,300 | $22,900 |
| Free cash flow | -$592,200 | -$912,400 | -$999,700 | -$3.78M | -$1.64M | -$1.69M | -$1.55M | $1.12M |
| Investing cash flow | $969,600 | $926,700 | $813,900 | $1.39M | $863,600 | $376,700 | $1.20M | $436,100 |
| Financing cash flow | $0 | $0 | $0 | -$100 | $500,100 | $1.45M | $0 | $0 |
| Depreciation & amortization | $56,300 | $50,800 | $55,300 | $151,800 | $137,200 | $154,300 | $166,700 | $185,300 |
| Stock-based compensation | $155,900 | $162,500 | $116,300 | $72,600 | $72,900 | $72,600 | $302,600 | $315,700 |
Free plan shows the latest 8 periods; Pro shows all 65 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.